Loading
Gynaecological medical oncologist directing the Cancer Center Clínica Universidad de Navarra; led the PRIMA trial of niraparib maintenance in ovarian cancer.
Antonio González-Martín is Director of the Cancer Center Clínica Universidad de Navarra (CCUN) and Co-Director of its Department of Medical Oncology. He is a leading gynaecological oncologist who served as principal investigator of the PRIMA/ENGOT-OV26 trial establishing niraparib first-line maintenance in advanced ovarian cancer, and has been president of the Spanish Ovarian Cancer Research Group (GEICO).
| Title | Journal | Year |
|---|---|---|
| Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | New England Journal of Medicine | 2019 |
| Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up | Annals of Oncology | 2023 |
| Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer | New England Journal of Medicine | 2016 |
Shares Endometrial cancer, Cervical cancer, Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer, gynaecological oncology.
Shares Endometrial cancer, Ovarian cancer and the tags leadership, clinician-scientist, gynaecological oncology.
Shares Endometrial cancer, Cervical cancer, Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares Endometrial cancer, Ovarian cancer and the tags leadership, clinician-scientist, gynaecological oncology.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares Endometrial cancer, Ovarian cancer and the tags leadership, clinician-scientist.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.